| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/14/1996 | EP0696190A1 Nasal aromatic releasing compositions |
| 02/13/1996 | US5491142 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 02/13/1996 | US5491141 Enzyme inhibitors, hypertensive agents; treating diuretic, congestive heart failure, aldosteronism, renal diseases, glaucoma |
| 02/13/1996 | US5491132 Amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same |
| 02/08/1996 | WO1996003399A1 Dihydrobenzofuranes |
| 02/08/1996 | WO1996003383A1 INDOLIZINE sPLA2 INHIBITORS |
| 02/08/1996 | WO1996003376A1 1H-INDOLE-1-FUNCTIONAL sPLA2 INHIBITORS |
| 02/08/1996 | WO1996003120A1 INDENE sPLA2 INHIBITORS |
| 02/08/1996 | CA2195570A1 Indolizine spla2 inhibitors |
| 02/08/1996 | CA2195569A1 1h-indole-1-functional spla2 inhibitors |
| 02/08/1996 | CA2195432A1 Indene spla2 inhibitors |
| 02/07/1996 | EP0695545A1 Use of diphenylethane derivatives for the treatment of glaucoma |
| 02/07/1996 | EP0695300A1 Novel 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents |
| 02/07/1996 | EP0695187A1 Compositions for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid |
| 02/07/1996 | EP0695182A1 Systems for controlled release of pilocarpine |
| 02/07/1996 | CN1030922C Process for preparation of new amino acid derivatives |
| 02/06/1996 | US5489592 3,4-dihydro-4-oxo-3-(2-propenyl)-1-phthalazineacetic acids and derivatives, their preparations and medicines containing them |
| 02/06/1996 | US5489585 Alkoxylated phenyl and coumarin derivatives useful in the treatment of viral infections |
| 02/01/1996 | WO1996002507A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis |
| 02/01/1996 | WO1996002257A1 Antisense oligonucleotides of pleiotrophin |
| 02/01/1996 | CA2195450A1 Antisense oligonucleotides of pleiotrophin |
| 02/01/1996 | CA2191975A1 Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis |
| 01/30/1996 | US5488151 {(7S)-7-[(2R)-2-(3-chlorophenyl)-2-hydroxyethylamino)-2-hydroxyethylamino]5,} acetic acid and its pharmaceutically acceptable salts |
| 01/30/1996 | US5488069 Antiinflammatory agents for eyes |
| 01/30/1996 | US5488050 Methods and products for treating presbyopia |
| 01/30/1996 | CA1338012C Pharmaceutically active amines |
| 01/25/1996 | WO1996001653A1 Methods and compositions for the specific coagulation of vasculature |
| 01/25/1996 | WO1996001646A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | CA2194550A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/24/1996 | EP0693277A1 Method for obstructing lacrimal canaliculi with infusible solution or dispersion |
| 01/23/1996 | US5486623 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 01/23/1996 | US5486540 Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents |
| 01/23/1996 | CA2154116A1 1-aryl-2-acetamidopentanone derivatives for use as tachykinin receptor antagonists |
| 01/17/1996 | EP0692472A1 Alpha-(4-chlorophenyl)- 4-(4-fluorophenylmethyl)-piperidine-1 -ethanol esters, their preparation and therapeutical use |
| 01/17/1996 | EP0691966A1 Quinolines as type iv phosphodiesterase inhibitors |
| 01/17/1996 | EP0436526B1 Use of antibodies to angiogenin: immunotherapeutic agents |
| 01/17/1996 | CN1114961A Peptide inhibitors of cell adhesion |
| 01/16/1996 | US5484811 Use of ethynyl alanine amino diol compounds for treatment of ophthalmic disorders |
| 01/16/1996 | US5484780 Angiotensin II antagonists |
| 01/16/1996 | US5484711 DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI |
| 01/16/1996 | CA2074454C Medicine based on neutralized sulphur derivatives |
| 01/14/1996 | CA2153726A1 .alpha.-(4-chlorophenyl)-4-[(4-fluorophenyl)-methyl]piperidine-1- ethanol esters, their preparation and their therapeutic application |
| 01/11/1996 | WO1996000716A1 New salts of 2-[(2,6-dichlorophenyl)amine]phenylacetoxyacetic acid with organic basic cations |
| 01/11/1996 | CA2192682A1 New salts of 2-¬(2,6-dichlorophenyl)amine|phenylacetoxyacetic acid with organic basic cations |
| 01/10/1996 | EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/10/1996 | EP0690859A1 Benzylimidazopyridine derivatives as angiotensin ii receptor antagonists |
| 01/10/1996 | EP0690854A1 1-phenyl-imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders |
| 01/10/1996 | EP0690720A1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 01/10/1996 | EP0639078A4 Method of treating eye disorders with silicone/fluorosilicone copolymer oil. |
| 01/10/1996 | EP0556241B1 Mycobacterium vaccae in the treatment of uveitis |
| 01/09/1996 | US5482941 Quinazolinone antianginal agents |
| 01/04/1996 | WO1996000238A1 T cell epitopes of rye grass pollen allergen |
| 01/04/1996 | WO1996000214A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 01/04/1996 | WO1996000073A1 Treatment of optic neuritis |
| 01/04/1996 | CA2193860A1 T cell epitopes of rye grass pollen allergen |
| 01/03/1996 | EP0689544A1 Process for production of an imidazole derivative |
| 01/03/1996 | EP0689438A1 Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine |
| 01/03/1996 | EP0689435A1 Use of substituted alkyl nitrates for the treatment of pathologically increased intra-ocular pressure |
| 01/03/1996 | EP0553130B1 Pyrrolidine dione derivatives |
| 01/03/1996 | CN1114318A Novel purine derivatives and pharmaceutically acceptable salts thereof |
| 01/03/1996 | CN1114310A 1H-indole-3-glyoxylamide spla2 inhibitors |
| 01/02/1996 | US5480972 Diagnosing, treating and preventing sensitivity; dna sequences |
| 01/02/1996 | US5480900 Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma |
| 01/02/1996 | US5480645 Hydroxyamines N-acyl derivatives having scavenger activity and useful in acute and chronic pathologies associated with peroxidation and inflammation phenomena |
| 12/28/1995 | WO1995035372A1 5-lipoxygenase-activating protein ii |
| 12/28/1995 | WO1995035314A1 Thiazolidine derivatives, their preparation and drugs containing same |
| 12/28/1995 | WO1995035310A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 12/28/1995 | WO1995035276A1 Metalloproteinase inhibitors |
| 12/28/1995 | WO1995035275A1 Metalloproteinase inhibitors |
| 12/28/1995 | CA2193692A1 Metalloproteinase inhibitors |
| 12/28/1995 | CA2193691A1 Metalloproteinase inhibitors |
| 12/27/1995 | EP0688337A1 Compositions and methods for the treatment of immunomediated inflammatory disorders |
| 12/27/1995 | EP0688211A1 Methods and compositions for inhibition of angiogenesis |
| 12/27/1995 | EP0553351B1 CRYSTALLINE MODIFICATION OF HYDROCHLORIDE OF 2-DIMETHYLAMINOETHYL ETHER OF n-BUTYLAMINO BENZOIC ACID, METHOD OF OBTAINING IT AND PHARMACEUTICAL PREPARATION FOR ANESTHESIA OF THE EYE BASED THEREUPON |
| 12/27/1995 | EP0418230B1 Method for potentiating and inhibiting insulin-like growth factor activity |
| 12/26/1995 | US5478938 Antagonists for angiotensin II receptors; hypotensive, cardiotonic agents; cognitive activators |
| 12/26/1995 | US5478858 Respiratory system disorders, gastrointestinal disorders |
| 12/26/1995 | US5478565 Treatment of sinus headache |
| 12/26/1995 | CA2021534C Antiallergic spray preparations |
| 12/21/1995 | WO1995022965A3 Nasal and ocular administration of ketamine to manage pain and for detoxification |
| 12/20/1995 | EP0687266A1 Heterocyclic compounds and their preparation and use |
| 12/20/1995 | EP0687265A1 Heterocyclic compounds and their preparation and use |
| 12/20/1995 | EP0687184A1 Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases |
| 12/20/1995 | EP0687179A1 Use of antiepileptics such as carbamazepine and oxcarbazepine for treating aids-related neural disorders |
| 12/20/1995 | EP0687177A1 Use of lamotrigine for treating aids-related neural disorders |
| 12/20/1995 | EP0687176A1 Use of riluzole for treating aids-related neural disorders |
| 12/20/1995 | EP0462258B1 Ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
| 12/19/1995 | US5476872 1,11-diesters of prostaglandin-F2α having a polar ester group at C-1 |
| 12/19/1995 | US5476860 Diaromatic compounds derived from a salicylic unit and their use in human and veterinary medicine and in cosmetics |
| 12/14/1995 | WO1995033752A1 Endothelin receptor antagonists |
| 12/14/1995 | WO1995033744A1 Tachykinin (nk1) receptor antagonists |
| 12/14/1995 | WO1995033712A1 Anti-inflammatory compounds |
| 12/14/1995 | WO1995033480A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 12/14/1995 | WO1995033475A1 Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis |
| 12/14/1995 | WO1995033461A1 Anti-inflammatory compounds |
| 12/14/1995 | WO1995033457A1 Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| 12/14/1995 | CA2704083A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 12/14/1995 | CA2192218A1 Use of copolymer-1 for the manufacture of a medicament for the treatment of optic neuritis |
| 12/14/1995 | CA2187531A1 Tachykinin (nk1) receptor antagonists |
| 12/13/1995 | EP0686629A2 Cyclohexyl tachykinine receptor antagonists |